Literature DB >> 14636880

APOA1 related amyloidosis: a case report and literature review.

Tisha Joy1, Jian Wang, Angelika Hahn, Robert A Hegele.   

Abstract

OBJECTIVES: Amyloidosis results from local or systemic extracellular deposition of insoluble protein fibrils and is associated with certain rare mutations in APOA1 encoding apolipoprotein (apo) A-I. DESIGN AND METHODS: In a patient with renal-predominant amyloidosis with neuropathy, we found the APOA1 G26R mutation.
CONCLUSIONS: While the spectrum of APOA1 mutations provides no particular mechanistic insights, molecular diagnosis may still be important due to clinical differences between amyloidosis resulting from mutation in APOA1 vs. other genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636880     DOI: 10.1016/s0009-9120(03)00110-3

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  18 in total

1.  Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.

Authors:  Chiharu Mizuguchi; Fuka Ogata; Shiho Mikawa; Kohei Tsuji; Teruhiko Baba; Akira Shigenaga; Toshinori Shimanouchi; Keiichiro Okuhira; Akira Otaka; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

Review 2.  Genetics of HDL-C: a causal link to atherosclerosis?

Authors:  Julian C van Capelleveen; Andrea E Bochem; M Mahdi Motazacker; G Kees Hovingh; John J P Kastelein
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

3.  Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.

Authors:  Madhu Nagappa; Arun B Taly; Anita Mahadevan; M Pooja; P S Bindu; Y T Chickabasaviah; N Gayathri; Sanjib Sinha
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

4.  Mass spectrometry analysis reveals non-mutated apolipoprotein A1 lumbosacral radiculoplexus amyloidoma.

Authors:  Adam J Loavenbruck; Vinay Chaudhry; Steven R Zeldenrust; Robert J Spinner; Jason D Theis; Christopher J Klein
Journal:  Muscle Nerve       Date:  2012-11       Impact factor: 3.217

Review 5.  Pathology and diagnosis of renal non-AL amyloidosis.

Authors:  Sanjeev Sethi; Jason D Theis
Journal:  J Nephrol       Date:  2017-08-21       Impact factor: 3.902

6.  Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.

Authors:  Chiharu Mizuguchi; Miho Nakagawa; Norihiro Namba; Misae Sakai; Naoko Kurimitsu; Ayane Suzuki; Kaho Fujita; Sayaka Horiuchi; Teruhiko Baba; Takashi Ohgita; Kazuchika Nishitsuji; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

7.  Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.

Authors:  Daria Maria Monti; Fulvio Guglielmi; Maria Monti; Flora Cozzolino; Silvia Torrassa; Annalisa Relini; Piero Pucci; Angela Arciello; Renata Piccoli
Journal:  Eur Biophys J       Date:  2010-02-25       Impact factor: 1.733

8.  Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.

Authors:  Dorota Rowczenio; Ahmet Dogan; Jason D Theis; Julie A Vrana; Helen J Lachmann; Ashutosh D Wechalekar; Janet A Gilbertson; Toby Hunt; Simon D J Gibbs; Prayman T Sattianayagam; Jenny H Pinney; Philip N Hawkins; Julian D Gillmore
Journal:  Am J Pathol       Date:  2011-08-05       Impact factor: 4.307

9.  Mapping the structural transition in an amyloidogenic apolipoprotein A-I.

Authors:  Jens O Lagerstedt; Giorgio Cavigiolio; Linda M Roberts; Hyun-Seok Hong; Lee-Way Jin; Paul G Fitzgerald; Michael N Oda; John C Voss
Journal:  Biochemistry       Date:  2007-08-01       Impact factor: 3.162

10.  Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?

Authors:  Adam J Loavenbruck; Wolfgang Singer; Michelle L Mauermann; Paola Sandroni; P James B Dyck; Morie Gertz; Christopher J Klein; Phillip A Low
Journal:  Ann Neurol       Date:  2016-07-25       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.